
Click to enlarge
Prenatal and Postnatal Care Rapid test RV TOXO CMV RSV Rapid test
Jiangsu, ChinaEvancare Medical (Nantong) Co., Ltd.
$0.21 - $0.46
MOQ500 Minimum
Lead Time
| Quantity | 旺季 | 淡季 |
|---|---|---|
| 1 - 2000 | 5 days | 5 days |
| 2001 - 10000 | 10 days | 10 days |
| 10001 - 100000 | 15 days | 15 days |
| > 100000 | To be negotiated | To be negotiated |
Product profile
- Format
- cassette
- Function
- Early Detection
- Instrument classification
- Class II
- Safety standard
- GB/T18830-2009
- Display
- screening
- Place of Origin
- Jiangsu, China
- Model Number
- EC-TOXO
- Power Source
- Manual
- Product name
- TOXO test
- Material
- Medical Grade ABS Plastic
- After-sale Service
- Online Technical Support
- Brand Name
- EVANCARE or Customized Logo
- Single package size
- 65X42X38 cm
- Shelf Life
- 3 Years
- Supply Ability
- 1000000 pieces per Day
- Accuracy
- 99%
- Quality Certification
- CE
- Package
- Single Pouch + Carton
- Packaging Details
- 1 pcs cassette+ 1 pcs disccant/ pouch, 25 pcs/ gift box, 20 gift box/ carton 1 20Ft container can load 550,000pcs cassettes. 1 40HQ container can load 1650,000pcs cassettes
- Method
- Colloidal Gold Rapid Test
- Single gross weight
- 20.000 kg
- Port of dispatch
- SHANGHAI /NINGBO/GUANGZHOU
- Warranty
- 3 Years
- Certificate
- CE ISO FSC
- Selling Units
- Single item
Company profile

Evancare Medical (Nantong) Co., Ltd.
南通盈泰医疗器械有限公司Jiangsu, ChinaRm. 1210, Bldg. 8, Tongfu Fuer Lecheng, Development Area Nantong Jiangsu China- CertifiedTrade Assurance
- Business Type: Trading Company
- Established: 2018
- Employees: 11 - 50 People
- Annual Export Value: US$2.5 Million - US$5 Million
- Avg. Response Time: ≤ 7h
- Certification: IVDR
Main Products
- Dengue Test
- Malaria Test
- HCG Test
- HIV Test
- Urine Analysis Test
Main Markets
Eastern Asia(18.00%), Africa(15.00%), Southeast Asia(10.00%), Domestic Market(10.00%), South America(9.00%), Western Europe(5.00%), Oceania(5.00%), Eastern Europe(5.00%), North America(5.00%), South Asia(5.00%), Mid East(5.00%), Southern Europe(3.00%), Central America(3.00%), Northern Europe(2.00%)





























